Elsevier Offers 950 New Health Titles to Research4Life
Leading health sciences publisher makes key Mosby, Saunders, Churchill Livingstone electronic titles freely available through UN developing world research access program
Amsterdam, NL October 12, 2011 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it is contributing an additional 950 electronic books to Research4Life, a public-private partnership working to achieve the UN’s Millennium Development Goals by providing developing world access to critical scientific research. Building on the 800 existing Elsevier science and technology books, the new electronic books cover Clinical Medicine (438 titles), Health Professions (332 titles), Veterinary Medicine (174 titles), and Clinical Dentistry (24 titles). These include seminal works such as Clinical Gynecology, Cancer Pain, Pain Medicine, Spinal Cord Injuries, and Saunders Manual of Small Animal Practice and will be accessible to users by the end of the year.
"Health practitioners and researchers in developing countries will benefit greatly from this increased ebooks offering, said Kimberly Parker, HINARI Programme Manager at the WHO, “We greatly appreciate the efforts made by Research4Life partners to continuously improve and update their content offering to those who need it most.”
“Contributing clinical titles helps to support doctors and nurses in the developing world to treat their patients and enhance their quality of life. It also benefits researchers in the developing world by providing them with access to critical, current information and supports them to become fully integrated into the international research community.” remarked Alicia Wise, Director of Universal Access at Elsevier, “Research4Life is central to our goal of achieving universal access to scientific, technical and medical information, so we’re very pleased to make this contribution and to work in partnership with everyone involved in Research4Life.”
Elsevier is a founding member of Research4Life and the leading contributor of content with over 1600 participating journals, 1800 electronic books and SciVerse Scopus, a web-integrated literature research tool with direct links to 18,000 full-text articles from 5,000 publishers. The program’s key partners include: WHO, FAO, UNEP, WIPO, Cornell and Yale Universities, the International Association of Scientific, Technical and Medical Publishers, 150 publishers and technology partner, Microsoft.
# # #
Research4Life is the collective name for four public-private partnerships which seek to help achieve the UN’s Millennium Development Goals by providing the developing world with access to critical scientific research. Since 2002, the four programmes, Health Access to Research (HINARI), Access to Global Online Research in Agriculture (AGORA), Online Access to Research in the Environment (OARE) and Access to Research for Development and Innovation (aRDi) program have given researchers at more than 5,000 institutions in 105 developing world countries free or low cost access to over 7,000 journals provided by the world’s leading science publishers. For more information please visit www.Research4Life.org and Research4Life YouTube channel.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact
Elsevier Corporate Relations Manager
+31 20 485 2025